Filter
34 of 34 peptides
-
Abaloparatide
Synthetic 34-amino-acid peptide modelled on PTHrP, studied for osteoporosis. UK prescription-only medicine; the main trial compared it with placebo.
StrongLicensed UK medicine -
Afamelanotide
Synthetic alpha-MSH analogue studied in erythropoietic protoporphyria (EPP). Licensed in the UK for adults with EPP; not recommended for routine NHS use. Not the same as Melanotan II.
ModerateLicensed UK medicine -
AOD-9604hGH Fragment 176-191
Growth hormone fragment studied for weight management. Not licensed in the UK; its largest human trial showed no significant weight-loss benefit.
ModerateNot licensed in the UK -
BPC-157Body Protection Compound-157
Synthetic gastric-derived peptide studied in animal models of tissue healing. Not licensed in the UK; human evidence is one small uncontrolled study.
LimitedNot licensed in the UK -
CJC-1295CJC-1295 with DAC
Long-acting growth-hormone-releasing hormone analogue studied for hormone levels in healthy adults. Not licensed in the UK; human evidence is small, short trials.
LimitedNot licensed in the UK -
Elamipretide
Synthetic four-amino-acid peptide studied in rare mitochondrial diseases. US accelerated approval for Barth syndrome; not authorised in the UK. A large phase 3 trial failed.
PreliminaryNot licensed in the UK -
EpithalonEpitalon
Synthetic four-amino-acid peptide studied in ageing research. Not licensed in the UK; evidence is mostly laboratory and animal work from one group.
LimitedNot licensed in the UK -
GHK-CuCopper peptide GHK
Copper-binding tripeptide studied for skin ageing and wound healing. Topical cosmetic use; no licensed injectable product in the UK.
LimitedNot licensed in the UK -
GHRP-2Pralmorelin
Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK; Japan licenses it only as a diagnostic test. No trial shows a health benefit.
LimitedNot licensed in the UK -
GHRP-6Growth hormone-releasing…
Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK. Human studies are short hormone-response and diagnostic work; no trial shows a health benefit.
LimitedNot licensed in the UK -
HexarelinExamorelin
Synthetic hexapeptide that triggers growth hormone release. Not licensed in the UK. In a long-term human study the response faded and IGF-I and body composition did not change.
LimitedNot licensed in the UK -
IpamorelinIPA
Synthetic growth hormone secretagogue studied for growth hormone release. Not licensed in the UK; human evidence is one small pharmacokinetic study.
LimitedNot licensed in the UK -
KisspeptinMetastin
Natural reproductive hormone studied in UK trials for low sexual desire and IVF egg maturation. No UK marketing authorisation identified.
LimitedNot licensed in the UK -
KPVLys-Pro-Val
Three-amino-acid fragment of alpha-MSH, studied in cell and mouse models of inflammation. Not licensed in the UK. No human trial of KPV was found.
PreliminaryNot licensed in the UK -
Melanotan IIMT-II
Synthetic melanocortin receptor agonist studied for skin tanning. Not licensed in the UK; human evidence is a three-volunteer pilot plus case reports.
LimitedNot licensed in the UK -
MOTS-cMitochondrial open reading…
16-amino-acid peptide encoded in mitochondrial DNA, studied in mice and cells. Not licensed in the UK. No published trial gave MOTS-c to people; human studies measured the body's own levels.
PreliminaryNot licensed in the UK -
Oxytocin
Natural hormone licensed in the UK for obstetric use; studied separately for social cognition, with mostly negative trial results.
LimitedLicensed for a different use -
PT-141 (Bremelanotide)Bremelanotide
No UK marketing authorisation found; authorised in the US. Selective melanocortin-4 receptor agonist studied for low sexual desire in women.
StrongNot licensed in the UK -
SelankTP-7
Synthetic tuftsin-derived peptide studied for anxiety. Not licensed in the UK; main human evidence is one active-comparator trial.
LimitedNot licensed in the UK -
SemaxACTH heptapeptide analog
Synthetic ACTH-derived peptide studied for brain function and stroke recovery. Not licensed in the UK; evidence is mainly rodent studies.
LimitedNot licensed in the UK -
SermorelinSermorelin acetate
Synthetic growth-hormone-releasing hormone fragment studied in children with growth hormone deficiency. Not licensed in the UK; evidence is mainly from before 2000.
LimitedNot licensed in the UK -
Setmelanotide
Synthetic peptide that activates the MC4 receptor, studied in rare forms of obesity. UK prescription-only medicine for three rare conditions; trials were small and do not cover common obesity.
ModerateLicensed UK medicine -
TB-500Thymosin Beta-4 fragment
Short synthetic fragment linked to thymosin beta-4. Not licensed in the UK. No human trials of TB-500 itself were found; trials of the full-length protein are not evidence for it.
LimitedNot licensed in the UK -
Teriparatide
34-amino-acid fragment of parathyroid hormone, studied for osteoporosis. UK prescription-only medicine; trials looked at spine and hip fractures.
StrongLicensed UK medicine -
TesamorelinTH9507
Not licensed in the UK. Growth-hormone-releasing hormone analogue studied for visceral fat in HIV-associated lipodystrophy, in randomised trials.
StrongNot licensed in the UK -
Thymosin Alpha-1Thymalfasin
Immune-regulating peptide studied in sepsis, pancreatitis and hepatitis B. Not licensed in the UK; meta-analyses show mixed results.
ModerateNot licensed in the UK -
Thymosin beta-4Thymosin β4
Natural 43-amino-acid peptide studied in eye and wound-healing trials. Not licensed in the UK. Trials were small with mixed results. It is not TB-500.
LimitedNot licensed in the UK
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.